<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03139240</url>
  </required_header>
  <id_info>
    <org_study_id>16845</org_study_id>
    <nct_id>NCT03139240</nct_id>
  </id_info>
  <brief_title>Opioid Analgesia for MAB</brief_title>
  <official_title>Opioid Analgesia for MAB: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Society of Family Planning</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our primary objective will be to determine if a strong opioid, oxycodone, given at a dose
      recommended for severe pain in addition to ibuprofen decreases maximum pain scores compared
      to ibuprofen and placebo in women undergoing medical abortion (MAB). Results of this study
      will help future providers understand whether prescribing opioids are an important adjunct
      for pain control in women undergoing MAB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will include 152 women undergoing MAB. Women will be randomized to oxycodone 10mg
      oral versus placebo and stratified by gestational age (&lt;7wks, 7-10wks). The primary outcome
      will be maximum reported pain score measured at 6-8 hours and 24 hours after misoprostol
      administration.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double Blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum self-reported pain score on a numeric rating scale</measure>
    <time_frame>24 hours after misoprostol administration</time_frame>
    <description>Women will text responses through two surveys within 24 hours after misoprostol administration indicating their maximum self-reported pain.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>MAB</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Gestational age &lt;7 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women with a gestational age &lt;7 weeks will be randomized to oxycodone 10mg oral vs placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gestational age 7-10w0d</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women with a gestational age 7-10w0d will be randomized to oxycodone 10mg oral vs placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone 10mg oral</intervention_name>
    <description>Oxycodone 10mg oral given for pain control in addition to standard of care medications in women undergoing medical abortion</description>
    <arm_group_label>Gestational age &lt;7 weeks</arm_group_label>
    <arm_group_label>Gestational age 7-10w0d</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo given in addition to standard of care medications in women undergoing medical abortion</description>
    <arm_group_label>Gestational age &lt;7 weeks</arm_group_label>
    <arm_group_label>Gestational age 7-10w0d</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 years or older

          -  Seeking elective medical abortion

          -  In good health

          -  Pregnancy with intrauterine gestational sac up to 10 0/7 weeks, dated by ultrasound

          -  Able and willing to receive text messages via phone

          -  Literate in English

          -  Able and willing to give informed consent and agree to the study terms

          -  Have assistance at home; no motor vehicle use while taking study medications

        Exclusion Criteria:

          -  Lack of access to cell phone and texting capabilities

          -  Early pregnancy failure

          -  Contraindications to the study medications: Oxycodone, Ibuprofen

          -  Contraindications to medical abortion with Mifepristone or Misoprostol

          -  History of methadone or heroin use

          -  Used alcohol in the past 24 hours

          -  Used marijuana &gt;4 times per week

          -  Any opioid in the past 30 days

          -  Using additional pain medications
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Site 1</name>
      <address>
        <city>Beaverton</city>
        <state>Oregon</state>
        <zip>97005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2017</study_first_submitted>
  <study_first_submitted_qc>May 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2017</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Alyssa Colwill</investigator_full_name>
    <investigator_title>MD, Instructor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

